DIRECT HEALTHCARE COSTS OF OPIOID ABUSE IN PATIENTS PRESCRIBED IMMEDIATE RELEASE HYDROCODONE IN THE UNITED STATES

被引：0
|
作者：
Michna, E. [1 ]
Chitnis, A. [2 ]
Paramore, C. [2 ]
Holly, P. [3 ]
Bell, J. A. [3 ]
BenJoseph, R. [3 ]
机构：
[1] Brigham & WomenaTMs Hosp, Chestnut Hill, MA USA
[2] Evidera, Lexington, MA USA
[3] Purdue Pharma LP, Stamford, CT USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.1728
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY30
引用
收藏
页码：A296 / A297
页数：4
相关论文
共 50 条
  • [1] RATES OF DIAGNOSED OPIOID ABUSE OR DEPENDENCE AND INCREMENTAL DIRECT HEALTH CARE COSTS AMONG PATIENTS WITH LONG-TERM USE OF IMMEDIATE RELEASE HYDROCODONE
    BenJoseph, R.
    Yang, E.
    Huse, S.
    Bhagnani, T. D.
    Holly, P.
    Kansal, A.
    VALUE IN HEALTH, 2014, 17 (07) : A527 - A528
  • [2] Direct Costs of Opioid Abuse in an Insured Population in the United States
    White, Alan G.
    Birnbaum, Howard G.
    Mareva, Milena N.
    Daher, Maham
    Vallow, Susan
    Schein, Jeff
    Katz, Nathaniel
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (10): : 1188 - 1198
  • [3] Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States
    Iwanicki, Janetta L.
    Severtson, S. Geoff
    McDaniel, Heather
    Rosenblum, Andrew
    Fong, Chunki
    Cicero, Theodore J.
    Ellis, Matthew S.
    Kurtz, Steven P.
    Buttram, Mance E.
    Dart, Richard C.
    PLOS ONE, 2016, 11 (12):
  • [4] An analysis of the abuse and associated deaths of immediate release opioid analgesics as compared to extended release formulations in the United States
    Bebarta, V. S.
    Severtson, S. G.
    Green, J. L.
    Dart, R. C.
    CLINICAL TOXICOLOGY, 2014, 52 (07) : 702 - 703
  • [5] SOCIETAL COSTS OF OPIOID ABUSE, DEPENDENCE, AND MISUSE IN THE UNITED STATES
    Birnbaum, H.
    White, A.
    Schiller, M.
    Waldman, T.
    Cleveland, J. M.
    Setnik, B. S.
    Pixton, G. C.
    Roland, C. L.
    VALUE IN HEALTH, 2010, 13 (03) : A111 - A111
  • [6] Characterizing Abuse Progression of Immediate-Release Hydrocodone Combination Products
    Beaumont, Jared
    Cassidy, Theresa A.
    Oyedele, Natasha
    Guenther, Sven
    Mickle, Travis C.
    JOURNAL OF DRUG ISSUES, 2018, 48 (03) : 312 - 326
  • [7] Societal Costs of Prescription Opioid Abuse, Dependence, and Misuse in the United States
    Birnbaum, Howard G.
    White, Alan G.
    Schiller, Matt
    Waldman, Tracy
    Cleveland, Jody M.
    Roland, Carl L.
    PAIN MEDICINE, 2011, 12 (04) : 657 - 667
  • [8] Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone
    Ben-Joseph, Rami
    Bell, Jill A.
    Brixner, Diana
    Kansal, Anuraag
    Paramore, Clark
    Chitnis, Abhishek
    Holly, Pamela
    Burgoyne, Douglas S.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2016, 22 (04): : 358 - 366
  • [9] Characterizing downstream healthcare resource utilization and costs based on prior utilization patterns of immediate-release hydrocodone
    Ben-Joseph, Rami
    Bell, Jill A.
    Chitnis, Abhishek
    Kansal, Anuraag
    Holly, Pamela
    Paramore, Clark
    Wild, Howard
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (02) : 169 - 180
  • [10] Estimation of Direct Healthcare Costs of Fungal Diseases in the United States
    Benedict, Kaitlin
    Jackson, Brendan R.
    Chiller, Tom
    Beer, Karlyn D.
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (11) : 1791 - 1797
12345